GLIMEPIRIDE vs GLOFITAMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GLIMEPIRIDE vs GLOFITAMAB: Safety Overview
| Metric | GLIMEPIRIDE | GLOFITAMAB |
|---|---|---|
| Total FAERS Reports | 5,572 | 1,116 |
| Deaths Reported | 552 | 315 |
| Death Rate | 9.9% | 28.2% |
| Hospitalizations | 2,550 | 492 |
| Average Patient Age | 66.6 yrs | 62.5 yrs |
| % Female Patients | 46.4% | 53.2% |
| FDA Approval Date | Apr 17, 2013 | N/A |
| Manufacturer | A-S Medication Solutions | Genentech, Inc. |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Discontinued | N/A |